Bionik Laboratories Corp. (BNKL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 5.81 Million USD | 1.56% |
| 2022 | 5.72 Million USD | -19.12% |
| 2021 | 7.07 Million USD | -43.02% |
| 2020 | 12.42 Million USD | 11.9% |
| 2019 | 11.1 Million USD | 7.24% |
| 2018 | 10.35 Million USD | 17.27% |
| 2017 | 8.82 Million USD | 33.12% |
| 2016 | 6.63 Million USD | 23150.74% |
| 2015 | 28.52 Thousand USD | 55.81% |
| 2014 | 18.3 Thousand USD | 10.92% |
| 2013 | 16.5 Thousand USD | 43.79% |
| 2012 | 11.47 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | - USD | -100.0% |
| 2024 Q2 | - USD | 0.0% |
| 2023 Q2 | 1.4 Million USD | -8.58% |
| 2023 FY | 5.81 Million USD | 1.56% |
| 2023 Q1 | 1.54 Million USD | 0.46% |
| 2023 Q4 | 1.55 Million USD | 18.06% |
| 2023 Q3 | 1.31 Million USD | -6.73% |
| 2022 Q4 | 1.53 Million USD | -7.63% |
| 2022 Q3 | 1.66 Million USD | 39.72% |
| 2022 Q2 | 1.18 Million USD | -11.48% |
| 2022 FY | 5.72 Million USD | -19.12% |
| 2022 Q1 | 1.34 Million USD | 3.12% |
| 2021 Q4 | 1.3 Million USD | -29.9% |
| 2021 Q1 | 2.11 Million USD | -35.12% |
| 2021 Q2 | 1.71 Million USD | -18.75% |
| 2021 FY | 7.07 Million USD | -43.02% |
| 2021 Q3 | 1.85 Million USD | 8.02% |
| 2020 Q2 | 3.4 Million USD | 29.83% |
| 2020 Q3 | 3.13 Million USD | -7.97% |
| 2020 Q4 | 3.26 Million USD | 4.09% |
| 2020 FY | 12.42 Million USD | 11.9% |
| 2020 Q1 | 2.62 Million USD | -14.38% |
| 2019 Q3 | 2.59 Million USD | 1.19% |
| 2019 FY | 11.1 Million USD | 7.24% |
| 2019 Q1 | 2.88 Million USD | 11.93% |
| 2019 Q2 | 2.56 Million USD | -11.09% |
| 2019 Q4 | 3.06 Million USD | 18.12% |
| 2018 Q2 | 3.51 Million USD | 65.41% |
| 2018 Q4 | 2.57 Million USD | 20.83% |
| 2018 Q1 | 2.12 Million USD | -37.04% |
| 2018 FY | 10.35 Million USD | 17.27% |
| 2018 Q3 | 2.13 Million USD | -39.43% |
| 2017 FY | 8.82 Million USD | 33.12% |
| 2017 Q2 | 1.8 Million USD | -11.1% |
| 2017 Q3 | 1.6 Million USD | -10.92% |
| 2017 Q4 | 3.37 Million USD | 109.89% |
| 2017 Q1 | 2.03 Million USD | 3.99% |
| 2016 Q1 | 2.43 Million USD | 95.23% |
| 2016 Q4 | 1.95 Million USD | 82.92% |
| 2016 Q3 | 1.06 Million USD | -9.65% |
| 2016 Q2 | 1.18 Million USD | -51.41% |
| 2016 FY | 6.63 Million USD | 23150.74% |
| 2015 Q1 | 5067.00 USD | 109.64% |
| 2015 FY | 28.52 Thousand USD | 55.81% |
| 2015 Q4 | 1.24 Million USD | 6763.46% |
| 2015 Q3 | 18.16 Thousand USD | 531.2% |
| 2015 Q2 | 2878.00 USD | -43.2% |
| 2014 Q1 | 6820.00 USD | 67.07% |
| 2014 FY | 18.3 Thousand USD | 10.92% |
| 2014 Q4 | 2417.00 USD | -41.51% |
| 2014 Q3 | 4132.00 USD | 26.17% |
| 2014 Q2 | 3275.00 USD | -51.98% |
| 2013 Q2 | 359.00 USD | 80.4% |
| 2013 Q3 | 12.61 Thousand USD | 3415.04% |
| 2013 Q4 | 4082.00 USD | -67.65% |
| 2013 FY | 16.5 Thousand USD | 43.79% |
| 2013 Q1 | 199.00 USD | -94.02% |
| 2012 Q1 | - USD | -100.0% |
| 2012 FY | 11.47 Thousand USD | 0.0% |
| 2012 Q4 | 3329.00 USD | -45.95% |
| 2012 Q3 | 6159.00 USD | 190.52% |
| 2012 Q2 | 2120.00 USD | 0.0% |
| 2011 Q4 | 3200.00 USD | 0.0% |
| 2011 Q2 | 6129.00 USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| The Amacore Group, Inc. | 64.06 Million USD | 90.924% |
| Arem Pacific Corporation | 367.08 Thousand USD | -1484.1% |
| Assisted 4 Living, Inc. | 833.9 Thousand USD | -597.312% |
| BioCorRx Inc. | 3.84 Million USD | -51.392% |
| Banyan Corp. | 6.59 Million USD | 11.863% |
| Clearday, Inc. | 5 Million USD | -16.235% |
| Dental Patient Care America, Inc. | 3.27 Million USD | -77.508% |
| Quantum Medical Transport, Inc. | 874.76 USD | -664644.158% |
| Empower Clinics Inc. | 6.92 Million USD | 15.998% |
| First Choice Healthcare Solutions, Inc. | 2.44 Million USD | -138.276% |
| Selectis Health, Inc. | 14.36 Million USD | 59.527% |
| Ethema Health Corporation | 5.27 Million USD | -10.296% |
| HealthLynked Corp. | 9.73 Million USD | 40.247% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 9.43 Million USD | 38.395% |
| JRSIS Health Care Corporation | 671.64 Thousand USD | -765.767% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 75.35 Million USD | 92.284% |
| MedSmart Group Inc. | 65.47 Thousand USD | -8781.667% |
| North America Frac Sand, Inc. | 775.75 Thousand USD | -649.582% |
| Nova Leap Health Corp. | 9.3 Million USD | 37.529% |
| Nexteligent Holdings, Inc. | 553.38 Thousand USD | -950.783% |
| PAO Group, Inc. | 45.42 Thousand USD | -12702.545% |
| Primemd Inc. | 6.25 Million USD | 7.078% |
| Raffles Medical Group Ltd | 151.69 Million USD | 96.167% |
| Ryman Healthcare Limited | 9.61 Million USD | 39.51% |
| Stem Cell Authority, Ltd. | 4233.00 USD | -137271.037% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 1.38 Million USD | -321.135% |
| Mycotopia Therapies, Inc. | 616.72 Thousand USD | -842.872% |
| U.S. NeuroSurgical Holdings, Inc. | 765 Thousand USD | -660.12% |
| Veltex Corporation | 1.77 Million USD | -227.212% |
| World Financial Holding Group | 28.42 Thousand USD | -20356.329% |
| Xcelerate Inc. | 2.9 Million USD | -100.046% |